GENE ONLINE|News &
Opinion
Blog

2022-04-21| Technology

These Two Companies are Helping Push Denmark to the Forefront of Biotech

by Reed Slater
Share To
Two Denmark-based biotech companies, SNIPR Biome and TOOsonix, are experiencing their own set of ‘firsts’ with their respective technologies. SNIPR Biome, which specializes in CRISPR-based therapies, will undergo its first Phase 1 clinical trial on humans to evaluate the safety and effectiveness of reducing Escherichia coli (E. coli) colonization using their novel CRISPR-based therapeutics, SNIPR001.

TOOsonix centers around high-intensity focused ultrasound (HIFU) systems for various skin treatments. They will take aim at Basal Cell Carcinoma (BCC) in their first clinical study on the treatment with their System ONE-M device, a HIFU system capable of focusing energy in hyper-specific locations and depths to target affected skin areas. 

Denmark is one of the leading nations in Europe in the biotechnology industry. In 2021 alone, Danish biotech startups received $434 million in venture capital to further pioneer life-saving medicines used globally. This article will highlight two such companies’ momentous strides in extending Denmark’s biotech industry internationally. 

GO Prime with only $1.49 now

LATEST
Preventive Medicine for Neurodegeneration on the Rise: New Breakthrough in Routine Blood Testing for Alzheimer’s Disease
2024-05-20
Discrimination Leads to Rapid Aging, Science Shows the Detrimental Effects of this Act
2024-05-17
A New Study has Linked Treatment Resistant Depression to Body Mass Index
2024-05-16
AI Reveals Sex-Related Brain Differences and Precision Medicine Potential
2024-05-16
The EU Sustainability Directive’s Influence on Pharmaceutical Supply Chains
2024-05-15
New UC Berkeley Study Challenges Traditional Views on Lactate and Carbohydrate Metabolism
2024-05-15
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
EVENT
Scroll to Top